Return to program book search
Adverse Drug Reactions: The Evidence and the Controversies
Tuition fee and ticket required for admission
Friday, March 21
Mile High Ballroom 2A
3:30 PM - 5:30 PM
David R. Adams, MD, PharmD, FAAD - Handout
- Joel M. Gelfand, MD, MSCE, FAAD
- Neil H. Shear, MD, FAAD
- Stephen E. Wolverton, MD, FAAD - Handout
Following this course, the attendee should be able to:
- Recognize many and some new adverse drug reactions/interactions in dermatology.
- Discuss the current diagnostic/treatment approaches to adverse drug reactions/interactions in dermatology.
- Define medicolegal risks for adverse drug reactions.
Over 100 adverse drug reactions (ADRs) affecting the skin, hair, or nails are noted in the literature. Drug interactions (DIs) are also a persistent potential risk with multi-drug regimens. We will discuss some of these reactions, some well known and others that occur less frequently or are newly reported. Most ADRs and DIs are self-limited and only require discontinuation of the suspected offending medication, while others are life-threatening and require intervention. Diagnostic approaches and difficulties will be discussed, as well as treatment strategies where indicated. Although in-depth basic science is still lacking in this field, we will discuss mechanisms where appropriate. Medicolegal issues will also be discussed.
|Friday, March 21|
|3:30 PM||Introduction: Adverse Drug Reactions / Dr. Adams|
|3:45 PM||Current Controversies in Safety of Dermatological Therapeutics / Dr. Gelfand|
|4:15 PM||Drug Interactions to Worry About / Dr. Shear|
|4:45 PM||Drug Safety and Medicolegal Risk / Dr. Wolverton|